Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.
This vulnerability carries a HIGH severity rating with a CVSS v3.1 score of 7.5, indicating it can be exploited remotely over the network with relatively low complexity without requiring user interaction and does not require pre-existing privileges . The vulnerability impacts confidentiality (data exposure), for affected systems. Impacting 1 product from zkteco organizations running these solutions should prioritize assessment and patching.
Reported in 2023, this vulnerability emerged during an era marked by increased sophistication in supply chain attacks, cloud infrastructure vulnerabilities, and software-as-a-service (SaaS) security challenges. Security practices during this period emphasized zero-trust architectures, container security, and API protection.
2023-08-03T23:15:11.473
2025-05-27T20:15:23.890
Modified
CVSSv3.1: 7.5 (HIGH)
SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For zkteco's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.